GFR-TKIs taken orally in cancer patients who have artery dissection and aneurysms.

Published Date: 04 Dec 2023

Unsettling data has been found about the relationship between oral Vascular Endothelial Growth and a recent nationwide cohort study carried out in Korea.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Belzutifan for Advanced Renal Cell Carcinoma is approved by the FDA.

2.

A Win for Molecularly Guided Therapy for Cancer of Unknown Primary

3.

Combination of significant weight gain and late motherhood greatly increases risk of breast cancer, study finds

4.

FDA Authorizes Three Different Uses for Injectable Antibiotic.

5.

Five new papers highlight cancer inequities, challenges and opportunities in South Asia


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot